Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Powell

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Journal of Translational Medicine|November 16, 2011
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysateCheryl L-L Chiang, Dawn A Maier, Lana E Kandalaft, et al.
JCO Precision Oncology|February 24, 2022
<i>PTEN</i> Loss and <i>BRCA1</i> Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian CancerAdam A Kraya, Kara N Maxwell, Monika A Eiva, et al.
Molecules (Basel, Switzerland)|December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor ResponseAladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
Gynecologic Oncology|December 11, 2019
An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancerSarah B Gitto, Hyoung Kim, Stavros Rafail, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2019
CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic MalignanciesAlba Rodriguez-Garcia, Prannda Sharma, Mathilde Poussin, et al.
Nature Communications|February 10, 2021
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapyAlba Rodriguez-Garcia, Rachel C Lynn, Mathilde Poussin, et al.
Oncoimmunology|March 14, 2013
Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancerLana E Kandalaft, Daniel J Powell, Cheryl L Chiang, et al.
Journal of the American Chemical Society|March 20, 2020
Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune ReceptorNicholas G Minutolo, Prannda Sharma, Mathilde Poussin, et al.
Gynecologic Oncology|January 30, 2024
CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survivalElizabeth A Tubridy, Monika A Eiva, Fang Liu, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Journal of Translational Medicine|November 16, 2011
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysateCheryl L-L Chiang, Dawn A Maier, Lana E Kandalaft, et al.
JCO Precision Oncology|February 24, 2022
<i>PTEN</i> Loss and <i>BRCA1</i> Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian CancerAdam A Kraya, Kara N Maxwell, Monika A Eiva, et al.
Molecules (Basel, Switzerland)|December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor ResponseAladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
Gynecologic Oncology|December 11, 2019
An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancerSarah B Gitto, Hyoung Kim, Stavros Rafail, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2019
CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic MalignanciesAlba Rodriguez-Garcia, Prannda Sharma, Mathilde Poussin, et al.
Nature Communications|February 10, 2021
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapyAlba Rodriguez-Garcia, Rachel C Lynn, Mathilde Poussin, et al.
Oncoimmunology|March 14, 2013
Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancerLana E Kandalaft, Daniel J Powell, Cheryl L Chiang, et al.
Journal of the American Chemical Society|March 20, 2020
Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune ReceptorNicholas G Minutolo, Prannda Sharma, Mathilde Poussin, et al.
Gynecologic Oncology|January 30, 2024
CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survivalElizabeth A Tubridy, Monika A Eiva, Fang Liu, et al.
Pageof 14